BiotechTube
Home/NeuroGenesis Bio/Mark Freedman
MF

Mark Freedman

Chief Medical Officer and Head of Scientific Advisory Board

NeuroGenesis Bio

Therapeutic Areas

Multiple SclerosisAmyotrophic Lateral SclerosisNeurodegenerative Diseases

NeuroGenesis Bio Pipeline

DrugIndicationPhase
NG CELLProgressive Multiple Sclerosis (MS)Phase 2

Leadership Team at NeuroGenesis Bio

DK
Dimitrios Karussis
Co-Founder and Chief Scientific Officer
IK
Ibrahim Kassis
Co-Founder and Chief Technology Officer
NN
Nir Netzer
Chief Operating Officer
DH
Dorit Harati
Senior VP Quality and Regulatory Affairs
View full NeuroGenesis Bio profile